Study Stopped
Main investigator changed affiliation.
Certainty Of Stroke Symptom Onset Study
COSSO
Observational Study on the Certainty of Stroke Symptom Onset
1 other identifier
observational
N/A
1 country
1
Brief Summary
Intravenous tissue plasminogen activator (IV t-PA) is the only proven treatment of hyperacute cerebral infarction. The outcome of this treatment highly depends on the time from symptom onset to the administration of thrombolytic agent. Last known normal time is widely used as the standard to determine the symptom onset. These stroke symptoms are usually caused by a sudden decrease in cerebral blood flow related with an embolic or thrombotic event. However, in some cases various symptoms may occur one after another. Myocardial infarction is also caused by a sudden caseation of blood flow. The symptom of myocardial infarction usually contains chest pain, and it is easy to identify the exact time of onset. In contrast, cerebral infarction may cause various symptoms according to the infarcted area of the brain, and sometimes multiple symptoms are presented in rapid succession. Therefore, it may be much unclear and uncertain to determine the onset time of cerebral infarction. Despite the importance of onset time in therapeutic decision making, there was no study focusing on the certainty of onset time in cerebral infarction patients. In this study, we will investigate the subjective certainty of patient about the onset time in clear-onset cerebral ischemia. The discrepancy in diagnosing the onset time will be analyzed among the clinicians involved in the practice. Then, the factors associated with this uncertainty will be verified.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
August 11, 2013
CompletedFirst Posted
Study publicly available on registry
August 27, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2014
CompletedJanuary 16, 2019
January 1, 2019
10 months
August 11, 2013
January 14, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Discrepancy (difference) in the time onset of stroke symptoms diagnosed by two different neurologists
The onset time assessed at emergency departement by a neurologist will be compared to the onset time assessed next day after admission by a different neurologist.
Onset time will be obtained two times,first at the visit time of emergency department (within 24 hours from onset) and secondly the day after admission (within 48 hours from onset)
Secondary Outcomes (2)
Factors influencing the subjective uncertainty of stroke symptom onset by patients
The subjective certainty will be obtained the day after admission (within 48 hours from onset)
Factor influencing the objective discrepancy of stroke symptom onset diagnosed by two different neurologists
The factors will be obtained the day after admission (within 48 hours from symptom onset)
Study Arms (1)
Discrepancy in stroke onset
Patients with discrepancy in stroke symptom onset based on the diagnosis of the first neurologist who evaluated the patient at emergency room and the next day after admission
Eligibility Criteria
Ischemic stroke patients admitted to Acute Stroke Unit at Asan Medical Center Patients older than 20 years old Symptom onset within 24 hours
You may qualify if:
- ischemic stroke patients admitted to Acute Stroke Unit at Asan Medical Center
- ischemic stroke patients older than 20 years old
- symptom onset within 24 hours
You may not qualify if:
- patients who cannot explain the symptom onset due to altered consciousness, aphasia, or cognitive decline
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Dong-Wha Kang
Seoul, 138-372, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Dong-Wha Kang, MD
Department of Neurology, Asan Medical Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
August 11, 2013
First Posted
August 27, 2013
Study Start
August 1, 2013
Primary Completion
June 1, 2014
Study Completion
August 1, 2014
Last Updated
January 16, 2019
Record last verified: 2019-01